期刊文献+

编码人B7-2胞外区cDNA的克隆、表达及生物活性鉴定 被引量:2

Cloning, Expression and Biological Activity Identification of a cDNA Encoding the Extracellular Region of Human B7-2
在线阅读 下载PDF
导出
摘要 B7 2分子是共刺激信号系统B7/CD2 8/CTLA 4中的重要成员之一 ,为了更深入地探讨B7 2分子在调控T细胞增殖、分化及相关信号传导过程中的作用 ,本研究通过聚合酶链式反应 (PCR)扩增编码人B7 2分子胞外区的cDNA ,测序后定向插入多个原核表达载体并诱导目的蛋白表达 ,用Western印迹和MTT鉴定生物活性。结果表明 :通过pGEX 4T 2载体实现了在宿主菌BL 2 1 (DE3) codenplus RIL中较高水平的表达 ,蛋白表达量为 2 0 %。经Western印迹和MTT鉴定 ,所表达及初步纯化的B7 2胞外区重组蛋白能与抗人B7 2单抗发生特异性结合 ;在抗人CD3单抗的协同下 ,B7 2胞外区重组蛋白能有效地促进外周血单核细胞的增殖。结论 :B7 2胞外区重组蛋白的获得为进一步研究B7 s As one important member of B7/CD28/CTLA 4 costimulatory signal pathway, B7 2 molecule plays a critical role in regulating T cell response. In order to further explore its effects on regulation of T cell activation, proliferation and associated signal pathways, the cDNA encoding extracellular region of human B7 2 was amplified via PCR and subcloned into some prokaryotic expression vectors to express target protein in host strains. The expressed protein was identified with Western blot and MTT. Results showed that after screening, the expression level of the protein of interest attained the yield of over 20% total bacterial protein by using pGEX 4T 2 vector and E.coli BL21(DE3) CodonPlus RIL host cells. The recombinant protein could specially react with B7 2 McAb and could stimulate T cell proliferation combined with anti CD3 antibody. In conclusion, the recombinant protein was bioactive,therefore the study will make it possible for the research of relationship between B7 2 structure and its function.
出处 《中国实验血液学杂志》 CAS CSCD 2002年第6期508-511,共4页 Journal of Experimental Hematology
基金 国家自然科学基金资助项目编号3990 0 187与 30 2 0 0 111 军队"九五"医学卫生科研基金资助项目编号 0 985
关键词 编码 人B7-2胞外区 CDNA 生物活性 鉴定 共刺激信号系统 原核表达 基因克隆 human B7 2 costimulatory signal pathway prokaryotic expression gene cloning
  • 相关文献

参考文献8

  • 1Greenfield EA, Nguyen KA, Kuchroo VK. CD28/B7 costimulation:a review. Crit Rev Immunol, 1998; 18:389 -418
  • 2Najafian N, Sayegh MH. CTLA4-Ig: a novel immunosuppressive agent. Expert Opin Investig Drugs, 2000; 9:2147-2157
  • 3Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. 2nd. New York: Cold Spring Harbor Laboratory Press, 1989: 1847-1858
  • 4Peitsch MC, Wilkins MR, Tonella L, et al. Large scale protein modelling and integration with the SWISS-PROT and SWISS2DPAGE databases: the example of Escherichia coli. Electrophoresis, 1997: 18:498- 501
  • 5Gerstmayer B, Pessara U, Wels W. Construction and expression in the yeast Pichia pastoris of functionally active soluble forms of the human costimulatory molecules B7-1 and B7-2 and the B7 counterreceptor CTLA-4. FEBS Lett, 1997; 407:63 - 65
  • 6McHugh RS, Ahmed SN, Wang YC, et al. Construction, purification, and functional incorporation on tumor cells of glycolipid-anchored human B7-1(CD80). Proc Ntal Acad Sci USA, 1995; 92:8059 - 8063
  • 7张建军,黄爱龙,罗娅,张定风.人CD80胞外区在大肠杆菌中的表达和鉴定[J].中华微生物学和免疫学杂志,1998,18(3):246-249. 被引量:1
  • 8Chen A, Meyerson HJ, Salvekar A, et al. Non-glycosylated B7-1 (CD80) retains the capacity to bind its counter-receptors. FEBSLett, 1998; 428:127- 134

二级参考文献3

同被引文献14

  • 1朱厚础.蛋白质纯化与鉴定实验指南[M].北京:科学出版社,2000.148-151.
  • 2袁志宏 孙玉英 关海容.分子构建并高通量筛选具有靶向杀伤CD28受体阳性T细胞的新型重组人B7—2—PE40KDEL外毒素融合蛋白[J].中国科学C,2005,.
  • 3Buchner J, Pastan I, Brinkmann U,et al.A method for increasing the yield of properly folded recombinant fusion proteins: single-chain immuno-toxins from renaturation of bacterial inclusion bodies[J].Anal Biochem,1992, 205(2):263-270.
  • 4Kreitman RJ, Pastan I.Purification and characterization of IL6-PE4E ,a recombinant fusion of interleukin 6 with Pseudomonas exotoxin[J]. Biocon Chem,1993, 4(6):581-585.
  • 5陈执中,章月华.现代生化药物与基因工程药物分析[M].上海:上海医科大学出版社,1999:67-87.
  • 6Marshak D R, Kadnag J T, Burgess P R et al. Strategies for protein purification and characterization [ M ]. New York:Cold Spring Harbor Laboratory Press, 1996:49-56.
  • 7夏其昌.蛋白化学研究技术与进展[M].北京:科学出版社,1999:1-7.
  • 8Tazzari P L, Polito L, Bolognesis Aet al: Immunotoxins containing recombinant anti-CTLA-4 single-chain fragment variable antibodies and saporin: in vitro results and in vivo effects in an acute rejection model [J]. J Immunol, 2001 ; 167 : 4222-4229.
  • 9Woodward J E, Schaefer A T, Zottola L Bet al. Inhibition of in vitro donor-specific proliferative and cytotoxic T cell responses in chimeric CD40 ligand-deficient bone marrow transplant recipients treated perioperatively with CTLA4-Ig [ J]. Transplant Proc, 2001; 33: 113- 114.
  • 10Howland K C, Ausubel L J, London C Aet al. The role of CD28 and CD40 ligand in T cell activation and tolerance [J]. J Immunol, 2000; 164 : 4465-4470.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部